DiscoverPractice Point® CME Podcasts: Expert Discussions in Immunology™
Practice Point® CME Podcasts: Expert Discussions in Immunology™
Claim Ownership

Practice Point® CME Podcasts: Expert Discussions in Immunology™

Author: Practice Point Communications

Subscribed: 0Played: 0
Share

Description

Welcome to our podcast where leading experts explore the fascinating world of the immune system and its critical role in health and disease. Each episode dives into the latest research, discoveries, and breakthroughs in immunology, covering topics from autoimmune diseases to immunotherapies. In these podcasts, leading immunologists offer a deep understanding of how the immune system protects us—and how it can sometimes go awry. These episodes provide expert knowledge and real-world applications in this ever-evolving field.

16 Episodes
Reverse
Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes.These podcast episodes are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules.Launch Date: March 27, 2025Release Date: March 27, 2025Expiration Date: February 28, 2026FACULTYAlice Gottlieb, MD, PhDClinical Professor, Icahn School of Medicine at Mount SinaiMark Lebwohl, MDDean for Clinical TherapeuticsIcahn School of Medicine at Mount SinaiProfessor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of DermatologyMount Sinai Health SystemPhilip Mease, MDDirector, Rheumatology Research, Providence Swedish MedicalClinical Professor, University of Washington School of MedicineThis podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes.These podcast episodes are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules.Launch Date: March 27, 2025Release Date: March 27, 2025Expiration Date: February 28, 2026FACULTYAlice Gottlieb, MD, PhDClinical Professor, Icahn School of Medicine at Mount SinaiMark Lebwohl, MDDean for Clinical TherapeuticsIcahn School of Medicine at Mount SinaiProfessor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of DermatologyMount Sinai Health SystemPhilip Mease, MDDirector, Rheumatology Research, Providence Swedish MedicalClinical Professor, University of Washington School of MedicineThis podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes.These podcast episodes are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules.Launch Date: March 27, 2025Release Date: March 27, 2025Expiration Date: February 28, 2026FACULTYAlice Gottlieb, MD, PhDClinical Professor, Icahn School of Medicine at Mount SinaiMark Lebwohl, MDDean for Clinical TherapeuticsIcahn School of Medicine at Mount SinaiProfessor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of DermatologyMount Sinai Health SystemPhilip Mease, MDDirector, Rheumatology Research, Providence Swedish MedicalClinical Professor, University of Washington School of MedicineThis podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
Vitiligo is a relatively common acquired pigmentation disorder. The therapeutic effect of all the treatment modalities varies considerably from individual to individual. As such, treatment must be individualized. Moreover, vitiligo can carry significant psychosocial impact. Healthcare providers play a crucial role in shaping patients' understanding of their condition, approach to treatment, and coping mechanisms. In this podcast series, Dr. Raj Chovatiya, along with his patient, will discuss ways to individualized treatment strategies and improve holistic care of patients with vitiligo. Launch Date: November 21, 2024 Release Date: November 21, 2024 Expiration Date: October 31, 2025 FACULTY Raj Chovatiya, MD, PhD, MSCI, FAAD Clinical Associate Professor Rosalind Franklin University Chicago Medical School Founder and Director Center for Medical Dermatology + Immunology Research Chicago, ILThis podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast. https://www.practicepointcme.com/CMEHome/ask-the-expert-emerging-evidence-to-improve-outcomes-in-vitiligo
Vitiligo is a relatively common acquired pigmentation disorder. The therapeutic effect of all the treatment modalities varies considerably from individual to individual. As such, treatment must be individualized. Moreover, vitiligo can carry significant psychosocial impact. Healthcare providers play a crucial role in shaping patients' understanding of their condition, approach to treatment, and coping mechanisms. In this podcast series, Dr. Raj Chovatiya, along with his patient, will discuss ways to individualized treatment strategies and improve holistic care of patients with vitiligo. Launch Date: November 14, 2024 Release Date: November 14, 2024 Expiration Date: October 31, 2025 FACULTY Raj Chovatiya, MD, PhD, MSCI, FAAD Clinical Associate Professor Rosalind Franklin University Chicago Medical School Founder and Director Center for Medical Dermatology + Immunology Research Chicago, ILThis podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast. https://www.practicepointcme.com/CMEHome/ask-the-expert-emerging-evidence-to-improve-outcomes-in-vitiligo
Estimated to impact at least 125 million people worldwide, the burden of living with psoriasis runs more than skin deep. From the physical impact and comorbidities to the emotional toll that may plague everyday life, many patients still struggle with inadequate disease control, often going untreated or undertreated, despite the myriad treatment options available. There is a significant need for new psoriasis treatment options, and this interactive program is designed to provide expert interpretation of new and emerging data on the treatment of psoriasis, with multidisciplinary expert perspectives on how new agents can impact clinical practice. This podcast will discuss how to help clinicians select the most appropriate treatment as well as address the significant health burdens and comorbidities experienced by many patients with psoriasis.Launch Date: August 15, 2024Release Date: August 15, 2024Expiration Date: July 31, 2025FACULTYBruce Strober, MD, PhDClinical ProfessorYale University and Central Connecticut UniversityThis podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/optimizing-outcomes-in-psoriasis-exploring-the-impact-of-rapid-diagnosis-and-emerging-therapeutic-agents
Hereditary Angioedema (HAE) poses significant challenges for patients and healthcare providers alike, with recurrent attacks impacting quality of life and posing risks of severe complications. While advancements in treatment options have improved acute management, there remains unmet needs in the realm of long-term prophylaxis. In this podcast series, Dr. Timothy Craig and Dr. Marc Riedl will delve into the complexities of HAE management, focusing specifically on emerging solutions for long-term prophylaxis. Through their discussions, they provide insights into the challenges faced by patients with HAE, the limitations of current prophylactic options, and the potential avenues for innovation and improvement in the long-term management of HAE.Launch Date: July 26, 2024Release Date: July 26, 2024Expiration Date: June 30, 2025FACULTYTimothy Craig, DO, FAAAAI, FACP, FACAAI, FACOITenured Professor of MedicinePediatrics and Distinguished EducatorPennsylvania State UniversityMarc Riedl, MD, MSProfessor of MedicineUniversity of California, San DiegoClinical Director - US HAEA Angioedema CenterUniversity of California, San DiegoThis podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/patient-centered-approaches-to-long-term-prophylaxis-in-hae-1
Hereditary Angioedema (HAE) poses significant challenges for patients and healthcare providers alike, with recurrent attacks impacting quality of life and posing risks of severe complications. While advancements in treatment options have improved acute management, there remains unmet needs in the realm of long-term prophylaxis. In this podcast series, Dr. Timothy Craig and Dr. Marc Riedl will delve into the complexities of HAE management, focusing specifically on emerging solutions for long-term prophylaxis. Through their discussions, they provide insights into the challenges faced by patients with HAE, the limitations of current prophylactic options, and the potential avenues for innovation and improvement in the long-term management of HAE.Launch Date: July 26, 2024Release Date: July 26, 2024Expiration Date: June 30, 2025FACULTYTimothy Craig, DO, FAAAAI, FACP, FACAAI, FACOITenured Professor of MedicinePediatrics and Distinguished EducatorPennsylvania State UniversityMarc Riedl, MD, MSProfessor of MedicineUniversity of California, San DiegoClinical Director - US HAEA Angioedema CenterUniversity of California, San DiegoThis podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/patient-centered-approaches-to-long-term-prophylaxis-in-hae-1
Hereditary Angioedema (HAE) poses significant challenges for patients and healthcare providers alike, with recurrent attacks impacting quality of life and posing risks of severe complications. While advancements in treatment options have improved acute management, there remains unmet needs in the realm of long-term prophylaxis. In this podcast series, Dr. Timothy Craig and Dr. Marc Riedl will delve into the complexities of HAE management, focusing specifically on emerging solutions for long-term prophylaxis. Through their discussions, they provide insights into the challenges faced by patients with HAE, the limitations of current prophylactic options, and the potential avenues for innovation and improvement in the long-term management of HAE.Launch Date: July 26, 2024Release Date: July 26, 2024Expiration Date: June 30, 2025FACULTYTimothy Craig, DO, FAAAAI, FACP, FACAAI, FACOITenured Professor of MedicinePediatrics and Distinguished EducatorPennsylvania State UniversityMarc Riedl, MD, MSProfessor of MedicineUniversity of California, San DiegoClinical Director - US HAEA Angioedema CenterUniversity of California, San DiegoThis podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/patient-centered-approaches-to-long-term-prophylaxis-in-hae-1
This is an accredited continuing education series of two (2) podcasts as downloadable audio files (MP3). In this podcast series, Dr. Scott Canna and Dr. Alexei Grom discuss diverse mechanisms and clinical presentations in patients with suspected MAS, approaches for the timely diagnosis of MAS, and considerations for appropriate treatment and management strategies. Launch Date: December 21, 2023 Release Date: December 21, 2023 Expiration Date: November 30, 2024 FACULTY Scott Canna, MD Assistant Professor of Pediatrics University of Pennsylvania Perelman School of Medicine Attending Physician, Rheumatology and Immune Dysregulation The Children's Hospital of Philadelphia Philadelphia, Pennsylvania Alexei Grom, MD Professor of Pediatrics Research Director Division of Rheumatology Cincinnati Children’s Hospital Medical Center Cincinnati, Ohio This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode. https://www.practicepointcme.com/CMEHome/expert-insights-on-mas-sjiaaosd-and-macrophage-activation-syndrome-an-interactive-case-based-discussion-37
This is an accredited continuing education series of two (2) podcasts as downloadable audio files (MP3). In this podcast series, Dr. Scott Canna and Dr. Alexei Grom discuss diverse mechanisms and clinical presentations in patients with suspected MAS, approaches for the timely diagnosis of MAS, and considerations for appropriate treatment and management strategies. Launch Date: December 21, 2023 Release Date: December 21, 2023 Expiration Date: November 30, 2024 FACULTY Scott Canna, MD Assistant Professor of Pediatrics University of Pennsylvania Perelman School of Medicine Attending Physician, Rheumatology and Immune Dysregulation The Children's Hospital of Philadelphia Philadelphia, Pennsylvania Alexei Grom, MD Professor of Pediatrics Research Director Division of Rheumatology Cincinnati Children’s Hospital Medical Center Cincinnati, Ohio This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode. https://www.practicepointcme.com/CMEHome/expert-insights-on-mas-sjiaaosd-and-macrophage-activation-syndrome-an-interactive-case-based-discussion-37
This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). During this podcast series, Drs Philip Mease and April Armstrong will inform and guide on keeping up with recent progress and safely integrating it into clinical treatment paradigms of PsA.Launch Date: December 15, 2023Release Date: December 15, 2023Expiration Date: November 30, 2024FACULTYPhilip Mease, MD, MACRDirector, Rheumatology ResearchSwedish Medical Center/ Providence St. Joseph HealthClinical ProfessorUniversity of Washington School of MedicineApril Armstrong, MD, MPHProfessor and ChiefDivision of DermatologyUniversity of California Los AngelesThis podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.https://www.practicepointcme.com/CMEHome/expert-insights-on-psa-how-do-personalized-treatment-options-transform-patient-outcomes-47
sdfdThis is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). During this podcast series, Drs Philip Mease and April Armstrong will inform and guide on keeping up with recent progress and safely integrating it into clinical treatment paradigms of PsA.Launch Date: December 15, 2023Release Date: December 15, 2023Expiration Date: November 30, 2024FACULTYPhilip Mease, MD, MACRDirector, Rheumatology ResearchSwedish Medical Center/ Providence St. Joseph HealthClinical ProfessorUniversity of Washington School of MedicineApril Armstrong, MD, MPHProfessor and ChiefDivision of DermatologyUniversity of California Los AngelesThis podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.https://www.practicepointcme.com/CMEHome/expert-insights-on-psa-how-do-personalized-treatment-options-transform-patient-outcomes-47
This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). During this podcast series, Drs Philip Mease and April Armstrong will inform and guide on keeping up with recent progress and safely integrating it into clinical treatment paradigms of PsA. Launch Date: December 15, 2023Release Date: December 15, 2023Expiration Date: November 30, 2024FACULTYPhilip Mease, MD, MACRDirector, Rheumatology ResearchSwedish Medical Center/ Providence St. Joseph HealthClinical ProfessorUniversity of Washington School of MedicineApril Armstrong, MD, MPH Professor and ChiefDivision of Dermatology University of California Los AngelesThis podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.https://www.practicepointcme.com/CMEHome/expert-insights-on-psa-how-do-personalized-treatment-options-transform-patient-outcomes-47
This is an accredited continuing education series of two (2) podcasts as downloadable audio files (MP3). Dr. Raj Chovatiya and Dr. David Rosmarin will provide expert interpretation of new data for current and emerging treatment options of vitiligo, along with practical considerations for how new agents can impact patient outcomes. Case presentations will be discussed to help clinicians select the most appropriate treatment as well as address the significant health burdens and complications experienced by many patients during treatment.Launch Date: November 8, 2023 Release Date: November 8, 2023 Expiration Date: October 31, 2024 FACULTYDavid Rosmarin, MD Chair Department of Dermatology Kapens Norrins Scholar Indiana University School of Medicine Indianapolis, Indiana Raj Chovatiya, MD, PhD, MSCI, FAAD Assistant Professor of Dermatology Northwestern University Feinberg School of Medicine Chicago, IllinoisThis podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.https://www.practicepointcme.com/CMEHome/expert-insights-on-vitiligo-how-do-emerging-treatment-options-have-the-potential-to-transform-patient-outcomes
This is an accredited continuing education series of two (2) podcasts as downloadable audio files (MP3). Dr. Raj Chovatiya and Dr. David Rosmarin will provide expert interpretation of new data for current and emerging treatment options of vitiligo, along with practical considerations for how new agents can impact patient outcomes. Case presentations will be discussed to help clinicians select the most appropriate treatment as well as address the significant health burdens and complications experienced by many patients during treatment.Launch Date: November 8, 2023 Release Date: November 8, 2023 Expiration Date: October 31, 2024 FACULTYDavid Rosmarin, MD Chair Department of Dermatology Kapens Norrins Scholar Indiana University School of Medicine Indianapolis, Indiana Raj Chovatiya, MD, PhD, MSCI, FAAD Assistant Professor of Dermatology Northwestern University Feinberg School of Medicine Chicago, IllinoisThis podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.https://www.practicepointcme.com/CMEHome/expert-insights-on-vitiligo-how-do-emerging-treatment-options-have-the-potential-to-transform-patient-outcomes
Comments